Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should Know
Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.
Read More
Expert: Hospital Pharmacists Play a Critical Role in Offsetting Opioid Addiction Levels
September 16th 2021September is National Recovery Month, so Pharmacy Times interviewed Rich Dion, PharmD, of Wolters Kluwer, Health, on the critical role of the hospital pharmacist in ongoing efforts to fight the opioid epidemic.
Watch
Oncology Overview: Tucatinib for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer
September 16th 2021Tucatinib is indicated to treat adults with advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer who have already received at least 1 anti-HER2-based regimen in the metastatic setting.
Read More
Practice Behavior Changes After Approval of Durvalumab in Review of Insurance Claims
September 16th 2021Dr. Jason Liu and his colleagues hoped to assess the use of maintenance durvalumab based on patient and physician characteristics among individuals with stage 3 NSCLC in the United States.
Read More
Tip of the Week: Utilize Implementation Science Concepts to Ensure Success of Value-Added Services
September 15th 2021iImplementation science is an emerging concept examining the development of services in a way that not only helps ensure their initial execution but also their sustainability over time.
Read More